Concepedia

Kevin Kelnar

KK

Statistics

Publications

20

Citations

7.8K

H-Index

18

Active since

2005

Affiliations

Mirna Therapeutics (United States)(Current)

Asuragen (United States)

The University of Texas MD Anderson Cancer Center

Woodward (United States)

Yale University

Kevin Kelnar is an author at Mirna Therapeutics (United States) specializing in molecular biology, molecular oncology, and microrna biology.

Publications per year

2005–2020

20

Publications

20

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Can Liu, Kevin Kelnar, Bigang Liu et al. · Nature Medicine · 2011 · 1.4K citations · Full text

Medicine, Molecular Biology, Oncology +14

The <i>let-7</i> MicroRNA Represses Cell Proliferation Pathways in Human Cells

Charles D. Johnson, Aurora Esquela‐Kerscher, Giovanni Stefani et al. · Cancer Research · 2007 · 1.2K citations · Full text

Life Sciences, Genetics, Oncology +17

Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

John Cogswell, James M. Ward, Ian A. Taylor et al. · Journal of Alzheimer s Disease · 2008 · 943 citations

Life Sciences, Molecular Biology, Neuroscience +17

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad et al. · British Journal of Cancer · 2020 · 912 citations · Full text

Medicine, Oncology, Pharmacology +13

Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34

Jason F. Wiggins, Lynnsie Ruffino, Kevin Kelnar et al. · Cancer Research · 2010 · 687 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

1–5 of 20